Search research articles
Contact Us
Filters
Showing results (221-230 of 466) with videos related to
Page
of 47
Sort By:
Gene
|
November 11, 2017
Drug response prediction in high-risk multiple myeloma
A J Vangsted, S Helm-Petersen, J B Cowland, et al.
International Journal of Radiation Biology
|
April 26, 2007
Reproductive death of cancer cells induced by femtosecond laser pulses
Jan Thøgersen, Cindy S Knudsen, Alice Maetzke, et al.
Plos One
|
March 5, 2020
Changes in SGLT2i and GLP-1RA real-world initiator profiles following cardiovascular outcome trials: A Danish nationwide population-based study
Jakob S Knudsen, Lisbeth M Baggesen, Maria Lajer, et al.
Age and Ageing
|
December 19, 2021
Development and validation of a model for predicting mortality in patients with hip fracture
Thomas J Hjelholt, Søren P Johnsen, Peter K Brynningsen, et al.
Oncogenesis
|
April 24, 2026
Cyclin E modulates vulnerability to CDC7 kinase inhibition
Adam P Dommer, Robert Kyne, Jianxin Wang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
October 7, 2017
Composite analysis of immunological and metabolic markers defines novel subtypes of triple negative breast cancer
Thomas A Adams, Paris J Vail, Amanda Ruiz, et al.
The Journal of Biological Chemistry
|
April 24, 2004
Hierarchical requirement of SWI/SNF in retinoblastoma tumor suppressor-mediated repression of Plk1
Ranjaka W Gunawardena, Hasan Siddiqui, David A Solomon, et al.
Familial Cancer
|
May 26, 2025
Pancreatic adenocarcinoma in a patient with a germline RB1 pathogenic variant
Riya Patel, Christos Fountzilas, Michael Horowitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2016
Immunologic and Metabolic Features of Pancreatic Ductal Adenocarcinoma Define Prognostic Subtypes of Disease
Jack Hutcheson, Uthra Balaji, Matthew R Porembka, et al.
British Journal of Cancer
|
August 25, 2023
PROTAC-mediated CDK degradation differentially impacts cancer cell cycles due to heterogeneity in kinase dependencies
Vishnu Kumarasamy, Zhe Gao, Bosheng Zhao, et al.
Page
of 47
Search research articles
Search
Showing results (221-230 of 466) with videos related to
Sort By:
Page
of 47
Gene
|
November 11, 2017
Drug response prediction in high-risk multiple myeloma
A J Vangsted, S Helm-Petersen, J B Cowland, et al.
International Journal of Radiation Biology
|
April 26, 2007
Reproductive death of cancer cells induced by femtosecond laser pulses
Jan Thøgersen, Cindy S Knudsen, Alice Maetzke, et al.
Plos One
|
March 5, 2020
Changes in SGLT2i and GLP-1RA real-world initiator profiles following cardiovascular outcome trials: A Danish nationwide population-based study
Jakob S Knudsen, Lisbeth M Baggesen, Maria Lajer, et al.
Age and Ageing
|
December 19, 2021
Development and validation of a model for predicting mortality in patients with hip fracture
Thomas J Hjelholt, Søren P Johnsen, Peter K Brynningsen, et al.
Oncogenesis
|
April 24, 2026
Cyclin E modulates vulnerability to CDC7 kinase inhibition
Adam P Dommer, Robert Kyne, Jianxin Wang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
October 7, 2017
Composite analysis of immunological and metabolic markers defines novel subtypes of triple negative breast cancer
Thomas A Adams, Paris J Vail, Amanda Ruiz, et al.
The Journal of Biological Chemistry
|
April 24, 2004
Hierarchical requirement of SWI/SNF in retinoblastoma tumor suppressor-mediated repression of Plk1
Ranjaka W Gunawardena, Hasan Siddiqui, David A Solomon, et al.
Familial Cancer
|
May 26, 2025
Pancreatic adenocarcinoma in a patient with a germline RB1 pathogenic variant
Riya Patel, Christos Fountzilas, Michael Horowitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2016
Immunologic and Metabolic Features of Pancreatic Ductal Adenocarcinoma Define Prognostic Subtypes of Disease
Jack Hutcheson, Uthra Balaji, Matthew R Porembka, et al.
British Journal of Cancer
|
August 25, 2023
PROTAC-mediated CDK degradation differentially impacts cancer cell cycles due to heterogeneity in kinase dependencies
Vishnu Kumarasamy, Zhe Gao, Bosheng Zhao, et al.
Page
of 47